Evidence map›Paper›PMID 41121000›Full record

ArticleBMC gastroenterology2025

Frailty and liver transplant eligibility beyond MELD scores: integrating functional status into candidate selection.

Maha Elsabaawy, Sameh Afify, Warda Othman, Amr Ragab

Abstract read
In one paragraph

Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maha ElsabaawyDepartment of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebeen El-Kom, Menoufia, Egypt. maha.ahmed@liver.menofia.edu.eg.ORCID http://orcid.org/0000-0002-3110-1547
Sameh AfifyDepartment of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebeen El-Kom, Menoufia, Egypt.
Warda OthmanDepartment of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebeen El-Kom, Menoufia, Egypt.
Amr RagabDepartment of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebeen El-Kom, Menoufia, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe MELD score, while central to liver transplant prioritization, fails to capture frailty, an important predictor of transplant eligibility and outcomes.

aimTo assess the impact of frailty on transplant eligibility and compare its predictive accuracy to MELD-Na.

methodsWe prospectively studied adults with cirrhosis referred to for transplant evaluation. Frailty was assessed using the Clinical Frailty Scale (CFS) by a multidisciplinary team, with adjudication for disagreements. Laboratory data were collected, MELD scores calculated, and transplant eligibility determined using our institutional framework. Correlation, logistic regression, and ROC analyses compared MELD and CFS in predicting eligibility.

resultsAmong 672 patients evaluated, 76 (11.3%) met the primary endpoint of transplant eligibility. Eligible patients had significantly lower MELD scores, but better frailty status compared with ineligible patients (mean CFS 3.2 vs. 5.8, p < 0.001). CFS correlated moderately with MELD (r = 0.62) and showed superior predictive accuracy for eligibility (AUC 0.84 vs. 0.72).

conclusionFrailty, assessed by the Clinical Frailty Scale, outperformed MELD-Na in predicting transplant eligibility and proved relevant even in low-MELD populations. These findings highlight frailty as a practical determinant of eligibility and a step toward standardized, evidence-based equitable selection frameworks.

Indexed as

Eligibility DeterminationEnd Stage Liver DiseaseFrailtyFunctional StatusLiver CirrhosisLiver TransplantationPatient SelectionAdultAgedFemaleHumansMaleMiddle AgedPredictive Value of TestsProspective StudiesSeverity of Illness IndexClinical frailty scaleFrailtyLiver transplantationMELDTransplant eligibility

Identifiers

PMID41121000
PMCPMC12538801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.